grazoprevir/elbasvir

Is Merck & Co. About to Derail Gilead Sciences?
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Merck
Gilead Sciences
grazoprevir/elbasvir
Viekira Pak
AbbVie
Flag link:
Merck Will Soon See a Decision on Its New Hepatitis C Therapy
Merck Will Soon See a Decision on Its New Hepatitis C Therapy
Yahoo/Market Realist
Merck
hepatitis C
grazoprevir/elbasvir
Flag link:
Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?
Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?
Bidness, ETC
Merck
Gilead Sciences
hepatitis C
MK-3682
grazoprevir/elbasvir
MK-8408
Flag link:
A Trio of Catalysts Lift Merck Higher in October
A Trio of Catalysts Lift Merck Higher in October
Motley Fool
Merck
Keytruda
grazoprevir/elbasvir
hepatitis C
earnings
Flag link:
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Merck
Gilead Sciences
AbbVie
hepatitis C
Viekira Pak
Harvoni
Sovaldi
grazoprevir/elbasvir
Flag link:
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Medical Marketing and Media
hepatitis C
Merck
grazoprevir/elbasvir
Gilead Sciences
Harvoni
Sovaldi
Flag link:
Merck Takes Aim at Gilead. Should You Worry?
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Flag link:
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Flag link:
Merck and Gilead square off in battle of the next-next-gen hep C combos
Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Merck
Gilead Sciences
hepatitis C
grazoprevir/elbasvir
GS-5816
GS-9857
Flag link:
Why Merck's Victory Is of Little Concern to Gilead
Why Merck's Victory Is of Little Concern to Gilead
Investopedia
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Sovaldi
Flag link:
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Merck
AbbVie
hepatitis C
Gilead Sciences
grazoprevir/elbasvir
Harvoni
Flag link:
Merck's potential HCV drug gets special FDA designation
Merck's potential HCV drug gets special FDA designation
Yahoo/AP
Merck
hepatitis C
FDA
grazoprevir/elbasvir
Flag link: